Forte Biosciences (FBRX) Return on Capital Employed (QoQ) (2017 - 2026)
Forte Biosciences (FBRX) Return on Capital Employed (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Forte Biosciences | 1.36 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,775.00 |
| Dec 31, 2025 | -4,239.00 |
| Sep 30, 2025 | 407.00 |
| Jun 30, 2025 | 3,496.00 |
| Mar 31, 2025 | 2,055.00 |
| Dec 31, 2024 | 14,595.00 |
| Sep 30, 2024 | -7,853.00 |
| Jun 30, 2024 | -8,280.00 |
| Mar 31, 2024 | -2,225.00 |
| Dec 31, 2023 | 1,513.00 |
| Sep 30, 2023 | -911.00 |
| Jun 30, 2023 | -3,648.00 |
| Mar 31, 2023 | -1,683.00 |
| Dec 31, 2022 | -387.00 |
| Sep 30, 2022 | 1,185.00 |
| Jun 30, 2022 | 453.00 |
| Mar 31, 2022 | 237.00 |
| Dec 31, 2021 | -41.00 |
| Sep 30, 2021 | -1,044.00 |
| Jun 30, 2021 | 4,784.00 |